These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31241554)

  • 1. EGF-GH Axis in Rat Steatotic and Non-steatotic Liver Transplantation From Brain-dead Donors.
    Álvarez-Mercado AI; Negrete-Sánchez E; Gulfo J; Ávalos de León CG; Casillas-Ramírez A; Cornide-Petronio ME; Bujaldon E; Rotondo F; Gracia-Sancho J; Jiménez-Castro MB; Peralta C
    Transplantation; 2019 Jul; 103(7):1349-1359. PubMed ID: 31241554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution.
    Zaouali MA; Padrissa-Altés S; Ben Mosbah I; Alfany-Fernandez I; Massip-Salcedo M; Casillas-Ramirez A; Bintanel-Morcillo M; Boillot O; Serafin A; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Liver Transpl; 2010 Sep; 16(9):1098-111. PubMed ID: 20818748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO-IL-6/10-IL-1β axis: a new pathway in steatotic and non-steatotic liver grafts from brain-dead donor rats.
    Casillas-Ramírez A; Micó-Carnero M; Sánchez-González A; Maroto-Serrat C; Trostchansky A; Peralta C
    Front Immunol; 2023; 14():1178909. PubMed ID: 37593740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cortisol in rat steatotic and non-steatotic liver transplantation from brain-dead donors.
    Jiménez-Castro MB; Negrete-Sánchez E; Casillas-Ramírez A; Gulfo J; Álvarez-Mercado AI; Cornide-Petronio ME; Gracia-Sancho J; Rodés J; Peralta C
    Clin Sci (Lond); 2017 Apr; 131(8):733-746. PubMed ID: 28246131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning.
    Jiménez-Castro MB; Meroño N; Mendes-Braz M; Gracia-Sancho J; Martínez-Carreres L; Cornide-Petronio ME; Casillas-Ramirez A; Rodés J; Peralta C
    J Hepatol; 2015 Jan; 62(1):83-91. PubMed ID: 25111175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of High-Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death.
    Cornide-Petronio ME; Negrete-Sánchez E; Mendes-Braz M; Casillas-Ramírez A; Bujaldon E; Meroño N; Martínez-Carreres L; Gracia-Sancho J; Rodés J; Jiménez-Castro MB; Peralta C
    Am J Transplant; 2016 Apr; 16(4):1148-59. PubMed ID: 26704922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.
    Gulfo J; Rotondo F; Ávalos de León CG; Cornide-Petronio ME; Fuster C; Gracia-Sancho J; Jiménez-Castro MB; Peralta C
    J Hepatol; 2020 Nov; 73(5):1131-1143. PubMed ID: 32422221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation.
    Jimenez-Castro MB; Casillas-Ramirez A; Massip-Salcedo M; Elias-Miro M; Serafin A; Rimola A; Rodes J; Peralta C
    Liver Transpl; 2011 Sep; 17(9):1099-110. PubMed ID: 21671350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.
    Elias-Miró M; Massip-Salcedo M; Raila J; Schweigert F; Mendes-Braz M; Ramalho F; Jiménez-Castro MB; Casillas-Ramírez A; Bermudo R; Rimola A; Rodes J; Peralta C
    Liver Transpl; 2012 Oct; 18(10):1198-208. PubMed ID: 22685091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Dietary Nutritional Treatment on Hepatic and Intestinal Damage in Transplantation with Steatotic and Non-Steatotic Liver Grafts from Brain Dead Donors.
    Micó-Carnero M; Casillas-Ramírez A; Caballeria-Casals A; Rojano-Alfonso C; Sánchez-González A; Peralta C
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.
    Zaoualí MA; Reiter RJ; Padrissa-Altés S; Boncompagni E; García JJ; Ben Abnennebi H; Freitas I; García-Gil FA; Rosello-Catafau J
    J Pineal Res; 2011 Mar; 50(2):213-21. PubMed ID: 21108657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors.
    Avalos-de León CG; Jiménez-Castro MB; Cornide-Petronio ME; Casillas-Ramírez A; Peralta C
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.
    Alfany-Fernandez I; Casillas-Ramirez A; Bintanel-Morcillo M; Brosnihan KB; Ferrario CM; Serafin A; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Am J Transplant; 2009 Mar; 9(3):439-51. PubMed ID: 19191767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
    Ben Mosbah I; Roselló-Catafau J; Alfany-Fernandez I; Rimola A; Parellada PP; Mitjavila MT; Lojek A; Ben Abdennebi H; Boillot O; Rodés J; Peralta C
    Liver Transpl; 2010 Feb; 16(2):163-71. PubMed ID: 20104484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.
    Casillas-Ramírez A; Zaouali A; Padrissa-Altés S; Ben Mosbah I; Pertosa A; Alfany-Fernández I; Bintanel-Morcillo M; Xaus C; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Endocrinology; 2009 Jul; 150(7):3153-61. PubMed ID: 19282385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ischemic preconditioning a useful strategy in steatotic liver transplantation?
    Fernández L; Carrasco-Chaumel E; Serafín A; Xaus C; Grande L; Rimola A; Roselló-Catafau J; Peralta C
    Am J Transplant; 2004 Jun; 4(6):888-99. PubMed ID: 15147422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors.
    Micó-Carnero M; Casillas-Ramírez A; Sánchez-González A; Rojano-Alfonso C; Peralta C
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
    Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Jackson KR; Motter JD; Haugen CE; Long JJ; King B; Philosophe B; Massie AB; Cameron AM; Garonzik-Wang J; Segev DL
    Transplantation; 2020 Aug; 104(8):1604-1611. PubMed ID: 32732837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody.
    Xiao Z; Banan B; Xu M; Jia J; Manning PT; Hiebsch RR; Gunasekaran M; Upadhya GA; Frazier WA; Mohanakumar T; Lin Y; Chapman WC
    Transplantation; 2016 Jul; 100(7):1480-9. PubMed ID: 27331362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.